Mark C. Petrie

47.1k total citations · 15 hit papers
317 papers, 16.9k citations indexed

About

Mark C. Petrie is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark C. Petrie has authored 317 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 251 papers in Cardiology and Cardiovascular Medicine, 72 papers in Surgery and 58 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark C. Petrie's work include Heart Failure Treatment and Management (144 papers), Cardiovascular Function and Risk Factors (117 papers) and Cardiac Imaging and Diagnostics (52 papers). Mark C. Petrie is often cited by papers focused on Heart Failure Treatment and Management (144 papers), Cardiovascular Function and Risk Factors (117 papers) and Cardiac Imaging and Diagnostics (52 papers). Mark C. Petrie collaborates with scholars based in United Kingdom, United States and Canada. Mark C. Petrie's co-authors include John J.V. McMurray, Pardeep S. Jhund, Nathaniel M. Hawkins, Lars Køber, Naveed Sattar, Michael R. MacDonald, Kieran F. Docherty, Søren Lund Kristensen, Andrew Davie and Rasmus Rørth and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Mark C. Petrie

297 papers receiving 16.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

2011 2.3k citations Mark C. Petrie et al. European Heart Journal profile →
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

2019 1.1k citations Pardeep S. Jhund, Kieran F. Docherty et al. profile →
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation

2012 763 citations Mark C. Petrie et al. profile →
Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

2010 651 citations Mark C. Petrie, John J.V. McMurray et al. European Journal of Heart Failure profile →
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy

2016 576 citations Eric J. Velazquez, Robert E. Michler et al. profile →
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

2008 503 citations Michael R. MacDonald, Mark C. Petrie et al. European Heart Journal profile →
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction

2021 155 citations Colin Berry, J. Paul Rocchiccioli et al. profile →
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF

2021 140 citations Kieran F. Docherty, Pardeep S. Jhund et al. European Heart Journal profile →
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

2023 129 citations Mark C. Petrie, Pardeep S. Jhund et al. European Heart Journal profile →
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

2024 123 citations Mikhail Kosiborod, Barry A. Borlaug et al. profile →
Heart failure with preserved ejection fraction: everything the clinician needs to know

2024 72 citations Matthew M.Y. Lee, Nathaniel M. Hawkins et al. profile →
Semaglutide and NT-proBNP in Obesity-Related HFpEF

2024 47 citations Mark C. Petrie, Barry A. Borlaug et al. Journal of the American College of Cardiology profile →
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis

2024 45 citations Deepak L. Bhatt, Mark C. Petrie et al. profile →
Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials

2024 43 citations Barry A. Borlaug, Javed Butler et al. European Heart Journal profile →
Inflammation in Obesity-Related HFpEF

2024 41 citations Subodh Verma, Mark C. Petrie et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Mark C. Petrie

Since Specialization

Citations

This map shows the geographic impact of Mark C. Petrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Petrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Petrie more than expected).

Fields of papers citing papers by Mark C. Petrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Petrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Petrie. The network helps show where Mark C. Petrie may publish in the future.

Co-authorship network of co-authors of Mark C. Petrie

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Petrie. A scholar is included among the top collaborators of Mark C. Petrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Petrie. Mark C. Petrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction 2024 ·Journal of the American College of Cardiology ·Subodh Verma, Javed Butler, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie, Sanjiv J. Shah, Thomas Jensen, Søren Rasmussen, Cecilia Rönnbäck, Béla Merkely, Evan L. O’Keefe, Mikhail Kosiborod	17
2	Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials 2024 ·European Heart Journal ·Linda Mellbin, Deepak L. Bhatt, (unknown), (unknown), Mark C. Petrie, Søren Rasmussen, Tina Vilsbøll	8
3	Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) 2024 ·European Heart Journal ·(unknown), (unknown), Colin Berry, Ross T. Campbell, Kieran F. Docherty, John Dreisbach, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Joanna Osmanska, Giles Roditi, Mark C. Petrie, (unknown), Matthew M.Y. Lee	2
4	Descriptive qualitative study of breathlessness and its management of Turkish individuals with self-reported heart failure 2024 ·BMJ Open ·(unknown), Mark C. Petrie, Simon Stewart, Bridget Johnston	3
5	Inflammation in Obesity-Related HFpEF breakdown → 2024 ·Journal of the American College of Cardiology ·Subodh Verma, Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman, Sanjiv J. Shah, Cecilia Rönnbäck, Steen Z. Abildstrøm, (unknown), Dennis Wolf, Dirk von Lewinski, Małgorzata Lelonek, Vojtěch Melenovský, Michele Senni, Mikhail Kosiborod	41
6	Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) 2023 ·European Heart Journal ·Matthew M.Y. Lee, Paul Welsh, Colin Berry, Katriona Brooksbank, Ross T. Campbell, Kieran F. Docherty, Joanna Osmanska, Giles Roditi, Kirsty Wetherall, Alex McConnachie, Patrick B. Mark, John J.V. McMurray, Pardeep S. Jhund, Mark C. Petrie, Naveed Sattar	0
7	Scar characterisation to predict arrhythmia and death in ischaemic cardiomyopathy: insights from the REVIVED trial 2023 ·European Heart Journal ·Holly Morgan, Amedeo Chiribiri, Salik Nazir, Pier Giorgio Masci, M. J. Ryan, Jennifer Mâncio, (unknown), Matthew Dodd, Tim Clayton, Roshan Weerackody, Peter O’Kane, John P. Greenwood, Mark C. Petrie, Christopher A. Rinaldi, Divaka Perera	1
8	A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies 2023 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Joanna Osmanska, Katriona Brooksbank, Kieran F. Docherty, (unknown), Kirsty Wetherall, Alex McConnachie, Jerry C. Hu, Roy S. Gardner, Andrew L. Clark, Iain Squire, Paul R. Kalra, Pardeep S. Jhund, Pieter Muntendam, John J.V. McMurray, Mark C. Petrie, Ross T. Campbell	5
9	Neuropeptide Y is Elevated in Heart Failure and is an Independent Predictor of Outcomes 2023 ·European Journal of Heart Failure ·(unknown), Carly Adamson, Colette E. Jackson, Ross T. Campbell, Paul Welsh, Mark C. Petrie, John J.V. McMurray, Pardeep S. Jhund, Neil Herring	16
10	Effects of intentional weight loss in patients with obesity and heart failure: a systematic review 2018 ·Obesity Reviews ·(unknown), Mark C. Petrie, (unknown), Jennifer Logue	48
11	Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme 2015 ·European Journal of Heart Failure ·(unknown), Ana Cristina Perez Moreno, Nathaniel M. Hawkins, Alan Brunton, Pardeep S. Jhund, Chih Wong, Scott D. Solomon, Christopher B. Granger, Salim Yusuf, Marc A. Pfeffer, Karl Swedberg, Roy S. Gardner, Mark C. Petrie, John J.V. McMurray	13
12	Clinical Characteristics and Outcomes of Patients with and without Diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) Trial 2015 ·European Journal of Heart Failure ·Michael R. MacDonald, Lilin She, Torsten Doenst, Philip F. Binkley, Jean L. Rouleau, Ru‐San Tan, Kerry L. Lee, Alan B. Miller, George Sopko, Dominika Szalewska, Myron A. Waclawiw, Rafał Dąbrowski, Serenella Castelvecchio, Christopher Adlbrecht, Robert E. Michler, Jae K. Oh, Eric J. Velazquez, Mark C. Petrie	19
13	Is Heart Rate a Risk Marker in Patients with Chronic Heart Failure and Concomitant Atrial Fibrillation? Results from the MAGGIC Meta-Analysis 2015 ·European Journal of Heart Failure ·Joanne Simpson, Davide Castagno, Robert N. Doughty, Katrina Poppe, Nikki Earle, Iain Squire, Mark Richards, Bert Andersson, Justin A. Ezekowitz, Michel Komajda, Mark C. Petrie, Finlay A. McAlister, Greg Gamble, Gillian Whalley, John J.V. McMurray	46
14	Spectral Microvolt T-Wave Alternans Testing has no Prognostic Value in Patients Recently Hospitalized with Decompensated Heart Failure 2013 ·European Journal of Heart Failure ·Colette E. Jackson, Rachel C. Myles, (unknown), Jonathan R. Dalzell, J. Paul Rocchiccioli, John R. Rodgers, R J Spooner, Nicola Greenlaw, Ian Ford, Roy S. Gardner, Stuart M. Cobbe, Mark C. Petrie, John J.V. McMurray	7
15	Use of Implantable Cardioverter Defibrillators in Patients with Left Ventricular Assist Devices 2012 ·European Journal of Heart Failure ·Stephen Pettit, Mark C. Petrie, Derek T. Connelly, Alan G. Japp, John Payne, Saleem Haj‐Yahia, Roy S. Gardner	21
16	Profile of Microvolt T-Wave Alternans Testing in 1003 Patients Hospitalized with Heart Failure 2012 ·European Journal of Heart Failure ·Colette E. Jackson, Rachel C. Myles, (unknown), Jonathan R. Dalzell, R J Spooner, John R. Rodgers, Vladimir Bezlyak, Nicola Greenlaw, Ian Ford, Stuart M. Cobbe, Mark C. Petrie, John J.V. McMurray	17
17	The Inter-Relationship of Diabetes and Left Ventricular Systolic Function on Outcome After High-Risk Myocardial Infarction 2010 ·European Journal of Heart Failure ·Amil M. Shah, Hajime Uno, Lars Køber, Eric J. Velazquez, Aldo P. Maggioni, Michael R. MacDonald, Mark C. Petrie, John J.V. McMurray, Robert M. Califf, Marc A. Pfeffer, Scott D. Solomon	39
18	Heart Failure and Chronic Obstructive Pulmonary Disease: Lung Function Test Interpretation: Reply 2009 ·European Journal of Heart Failure ·Nathaniel M. Hawkins, Mark C. Petrie, Pardeep S. Jhund, George Chalmers, Francis G. Dunn, John J.V. McMurray	0
19	Heart Failure and Chronic Obstructive Pulmonary Disease: Diagnostic Pitfalls and Epidemiology 2009 ·European Journal of Heart Failure ·Nathaniel M. Hawkins, Mark C. Petrie, Pardeep S. Jhund, George Chalmers, Francis G. Dunn, John J.V. McMurray	402
20	Red Cell Distribution width has Incremental Prognostic Value to B-Type Natriuretic Peptide in Acute Heart Failure 2009 ·European Journal of Heart Failure ·Colette E. Jackson, Jonathan R. Dalzell, Vladimir Bezlyak, (unknown), Rachel C. Myles, R J Spooner, Ian Ford, Mark C. Petrie, Stuart M. Cobbe, John J.V. McMurray	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact